ANTI-TUBERCULOSIS DRUG RESISTANCE AND HIV CO-INFECTION IN PHNOM PENH, CAMBODIA

被引:0
|
作者
Sar, Borann [1 ]
Keo, Chantary [1 ]
Leng, Chanthy [2 ]
Saman, Manil [2 ]
Min, Doung Chan [2 ]
Chan, Sarin [2 ]
Monchy, Didier [1 ]
Sarthou, Jean-Louis [1 ,2 ]
机构
[1] Inst Pasteur Cambodge, Lab Mycobacteriol, Unit Clin Testing, Phnom Penh, Cambodia
[2] Inst Pasteur Cambodge, Dept Epidemiol, Phnom Penh, Cambodia
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The objective of this study was to observe the prevalence of drug resistance in Mycobacterium tuberculosis isolates in HIV associated tuberculosis co-infected patients in Phnom Penh City. The isolates of M. tuberculosis were collected during active laboratory-based surveillance. Of the 98 isolates studied, M. tuberculosis resistance to isoniazid was seen in 23.5%, resistance to rifampicin was seen in 16.3% and multidrug-resistance (MDR-TB) was seen in 5.1%. Our findings reveal an alarmingly high level of resistance to isoniazid and rifampicin, and confirms the need for drug susceptibility testing to guide treatment in patients with culture positive tuberculosis.
引用
收藏
页码:104 / 107
页数:4
相关论文
共 50 条
  • [31] Anti-tuberculosis drug resistance in Dohuk, Iraq
    Merza, Muayad A.
    Farnia, Parissa
    Masjedi, Mohammad Reza
    Ridell, Malin
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2010, 14 (09) : 1213 - 1214
  • [32] ANTI-TUBERCULOSIS DRUG RESISTANCE IN SOUTHEAST OF TURKEY
    Dal, Tuba
    Ozcan, Nida
    Tekin, Recep
    Tekin, Alicem
    Celen, Mustafa Kemal
    Ozekinci, Tuncer
    Dal, T.
    Ozcan, N.
    Tekin, R.
    Tekin, A.
    Celen, M. K.
    Ozekinci, T.
    ACTA MEDICA MEDITERRANEA, 2013, 29 (01): : 41 - 46
  • [33] Increasing anti-tuberculosis drug resistance in the UK
    Kruijshaar, M. E.
    Watson, J. M.
    Drobniewski, F.
    Anderson, C.
    Magee, J. G.
    Smith, E. G.
    Abubakar, I.
    THORAX, 2007, 62 : A4 - A5
  • [34] Spectrum of opportunistic infections in hospitalized HIV-infected patients in Phnom Penh, Cambodia
    Senya, C
    Mehta, A
    Harwell, JI
    Pugatch, D
    Flanigan, T
    Mayer, KH
    INTERNATIONAL JOURNAL OF STD & AIDS, 2003, 14 (06) : 411 - 416
  • [35] Therapeutic outcomes of anti-tuberculosis treatment in the context of HIV-tuberculosis co-infection: Cohort of Kabinda Center in Kinshasa, Democratic Republic of Congo
    Akilimali, P. Z.
    Tshilumbu, J. M. K.
    Mavila, A. K.
    Kaba, D. K.
    REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2015, 63 (06): : 387 - 393
  • [36] The scourge of tuberculosis and anti-tuberculosis drug resistance in Eastern Europe
    Cox, Helen
    Ford, Nathan
    PUBLIC HEALTH ACTION, 2014, 4 : S1 - S2
  • [37] First National Workshop on Antibiotic Resistance in Cambodia: Phnom Penh, Cambodia, 16-18 November 2011
    Vlieghe, E.
    Sary, S.
    Lim, K.
    Sivuthy, C.
    Phe, T.
    Parry, C.
    De Smet, B.
    Monidarin, C.
    Baron, E.
    Moore, C. E.
    Mfuko, W.
    Asgari, N.
    Chhorvoin, O.
    Steenkeste, N.
    Leyer, C.
    van Griensven, J.
    Thai, S.
    Jacobs, J.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2013, 1 (01) : 31 - 34
  • [38] Treatment Outcomes for Extensively Drug-Resistant Tuberculosis and HIV Co-infection
    O'Donnell, Max R.
    Padayatchi, Nesri
    Kvasnovsky, Charlotte
    Werner, Lise
    Master, Iqbal
    Horsburgh, C. Robert, Jr.
    EMERGING INFECTIOUS DISEASES, 2013, 19 (03) : 416 - 424
  • [40] Anti-tuberculosis drug resistance in Ethiopia: systematic review
    Weldegebreal, S.
    Mebrahtut, T.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2017, 21 (01) : 18 - 22